PROTEOR, a prosthetics and orthotics (O&P) firm, has expanded its Digital options by 3D printing non-vase mode definitive sockets, using a proprietary materials, KyronMAX, sourced from an unique partnership with Mitsubishi Chemical Group. This materials, which provides elevated tensile energy and toughness qualities, allows 3D printed PROTEOR sockets to exceed ISO 10328 requirements when using the PROTEOR ICARUS 3D printer.
The 3D printing methodology utilized by PROTEOR ensures medical efficiencies, constant high quality and sturdiness, and a tailor-made match for every particular person. By increasing its providing to incorporate a non-vase mode design, PROTEOR bridges the hole between cutting-edge know-how and real-world wants.
“We’re dedicated to offering our clients with probably the most superior 3D printing applied sciences out there at this time – together with the highest-quality filaments out there,” mentioned Mike Gorski, Normal Supervisor of Proteor Printing Options. “PROTEOR is delivering what the trade has been ready for – in-house 3D printed Definitive sockets with a streamlined workflow course of. On this trade, I’ve discovered loads from our clients on how this course of must be simplified. After the acquisition of Filament Improvements, I introduced this data to PROTEOR and the groups created a streamlined workflow course of round definitive sockets. Using the ORTEN software program, an ICARUS 3D printer, and KyronMAX materials, definitive prosthetic sockets can now be 3D printed in-house inside just a few hours. That is the technological revolution the trade has been ready for. I’m thrilled to announce there isn’t a extra wait, this know-how is prepared at this time and has been scientifically validated.”
The corporate is getting ready to launch its complete PROTEOR Digital Suite in Might – an expansive digital options platform that features improvements in scanning, software program, and printing providers. This built-in system is designed to streamline workflows and improve each affected person outcomes and medical effectivity.
